Clinical reports have also indicated that a high-expression level of BMP-7 may serve as a biomarker for metastasis and poor prognosis in various malignancies, such as esophageal cancer [38], lung cancer [18], gastric cancer [3], colorectal cancer [15], liver cancer [39], and melanoma [5]. This evidence concerns the gene BMP7 and liver cancer.